Zidometacin

Zidometacin is a nonsteroidal anti-inflammatory agent that primarily targets prostaglandin synthesis, effectively reducing inflammation with a diminished risk of gastrointestinal toxicity. It exhibits notable antinociceptive and antipyretic properties, demonstrating low ulcerogenic potential in rat models. Zidometacin is applicable in research focused on analgesia and osteoarthritis, contributing valuable insights into pain management and inflammatory processes.